Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHD (IDEAL)

Pfizer

Status and phase: Completed; Phase 4

Conditions: Cardiovascular Diseases

Treatments: Drug: atorvastatin; Drug: simvastatin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00159835

ATV-N-98-001

A2581145

Details and patient eligibility

About

To investigate whether a long-term strategy to lower LDL cholesterol with atorvastatin as much as possible will improve prognosis in CHD patients compared with a strategy reflecting current best clinical practice with simvastatin.

Sex: All

Ages: Under 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Previous myocardial infarction

Exclusion criteria

• Women who are breast feeding or are pregnant

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)